Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FTC orders with Del, Pfizer, Care Technologies

This article was originally published in The Tan Sheet

Executive Summary

Give final approval to separate consent orders regarding Del's Pronto shampoo, Pfizer's RID shampoo and egg removal comb and Care Technologies' Clear shampoo and lice egg remover to settle allegations the companies made false and unsubstantiated claims for the OTC head lice treatments. Proposed in September, the orders require that for two years, whenever a claim is made regarding product efficacy, the marketers include a disclosure about the necessity of a second treatment application ("The Tan Sheet" Sept. 28, 1998, p. 22). While the commission vote to make the orders final was unanimous, Commissioner Orson Swindle reiterated his concern about the disclosure requirement. The order against Del also prohibits claims about the extent to which health care professionals recommend Baby Orajel

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS089239

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel